Screeners
Heatmaps
Trends
News

You're viewing limited data.

Sign up

1 asset

Market news

TypeAll

SortNewest

Assets

MGX

Type

TypeAll

All

Sort

SortNewest

Newest

Filter by asset

Metagenomi director Laurence Reid buys $23,401 in company stock

Sep 12Investing.com

Metagenomi general counsel Matthew Wein sells $414 in stock

Sep 10Investing.com

Metagenomi CFO Pamela Wapnick sells $2,213 in tax-related stock

Sep 10Investing.com

Metagenomi at Wells Fargo conference: hemophilia program advances

Sep 10Investing.com

Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference

Sep 1Barchart.com

Analysts’ Top Healthcare Picks: Metagenomi, Inc. (MGX), Kymera Therapeutics (KYMR)

Detailed price information for Kymera Therapeutics Inc (KYMR-Q) from The Globe and Mail including charting and trades.

Aug 12The Globe and Mail

Wells Fargo cuts Metagenomi stock price target on higher R&D costs

Aug 11Investing.com

Metagenomi Therapeutics (MGX) Reports Q2 Loss, Lags Revenue Estimates

Aug 10Yahoo Finance

Metagenomi Therapeutics: Q2 Earnings Snapshot

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Aug 10Yahoo Finance

Chardan initiates Metagenomi stock with buy, $5 target on gene therapy potential

Jul 7Investing.com

This is the newest page. Registered accounts read further back.